The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Basic Science of Pulmonary Arterial Hypertension for Clinicians: New Concepts and Experimental Therapies
Open accessAbstract
Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) failure and a 15% annual mortality rate. The present review highlights recent advances in the basic science of PAH. New concepts clarify the nature of PAH and provide molecular blueprints that explain how PAH is initiated and maintained. Five basic science concepts provide a framework to understand and treat PAH: (1) Endothelial dysfunction creates an imbalance that favors vasoconstriction, thrombosis, and mitogenesis. Restoration of this balance by inhibition of endothelin and thromboxane or augmentation of nitric oxide (NO) and prostacyclin is the paradigm on which most current therapy is based. (2) PAH has a genetic component. Mutations (bone morphogenetic protein receptor-2 [BMPR2]) and single-nucleotide polymorphisms (SNPs; ion channels and transporter genes) predispose to PAH. (3) Excess proliferation, impaired apoptosis, and glycolytic metabolism in pulmonary artery smooth muscle, fibroblasts, and endothelial cells suggest analogies to cancer. Many experimental therapies reduce PAH by decreasing the proliferation/apoptosis ratio; these include inhibitors of pyruvate dehydrogenase kinase (PDK), serotonin transporters (SERT), survivin, 3-hydroxy-3-methylglutaryl coenzyme A reductase, transcription factors (hypoxia-inducible factor [HIF]-1α and nuclear factor of activated T lymphocytes [NFAT]), and tyrosine kinases. Augmentation of voltage-gated K+ channels (Kv1.5) and BMPR2 signaling also addresses this imbalance. Tyrosine kinase inhibitors used to treat cancer are currently in phase 1 PAH trials. (4) Refractory vasoconstriction may occur due to rho kinase activation. Fewer than 20% of PAH patients respond to conventional vasodilators; however, refractory vasoconstriction may respond to rho kinase inhibitors. (5) The RV can be targeted therapeutically. Although increased afterload initiates RV failure, which is the major cause of death/dysfunction in PAH, the RV may be amenable to cardiac-targeted therapies. The RV in PAH has features of ischemic, hibernating myocardium. Guided by these new …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Self-citationLane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Giaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Organization and regulation of mitogen-activated protein kinase signaling pathways
Garrington, T. P., & Johnson, G. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80028-3 · Cited by 1,275
Signal Transduction by the TGF-β Superfamily
Attisano, L., & Wrana, J. L. (2002) · Science · doi:10.1126/science.1071809 · Cited by 1,268
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Voelkel, N. F., Quaife, R. A., Leinwand, L. A., Barst, R. J., McGoon, M. D., Meldrum, D. R., Dupuis, J., Long, C. S., Rubin, L. J., Smart, F. W., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.632208 · Cited by 1,250
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Christman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Primary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V, Steele, P. M., Edwards, W. D., Gersh, B. J., McGoon, M. D., & Frye, R. L. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,066
Reversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
Potter, L. R., Abbey-Hosch, S., & Dickey, D. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0014 · Cited by 1,002
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D. J., Levy, R. D., Cernacek, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980
An epidemiological study of pulmonary arterial hypertension
Peacock, A. J., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 792
Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W., & Stasch, J.-P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2038 · Cited by 749
Thomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M., Elliott, G. C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 732
Rubin, L. J., Mendoza, J., Hood, M., McGoon, M., Barst, R., Williams, W. B., Diehl, J. H., Crow, J., & Long, W. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-485 · Cited by 706
Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Condliffe, R., Kiely, D. G., Peacock, A. J., Corris, P. A., Gibbs, J. S. R., Vrapi, F., Das, C., Elliot, C. A., Johnson, M., DeSoyza, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-953oc · Cited by 657
Simonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., Frost, A. E., Engel, P. J., Kramer, M. R., Burgess, G., Collings, L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00004 · Cited by 616
Survival with first-line bosentan in patients with primary pulmonary hypertension
McLaughlin, V. V., Sitbon, O., Badesch, D. B., Barst, R. J., Black, C., Galiè, N., Rainisio, M., Simonneau, G., & Rubin, L. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00054804 · Cited by 602
Inflammation in pulmonary arterial hypertension
Dorfmüller, P., Perros, F., Balabanian, K., & Humbert, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00038903 · Cited by 594
Bonnet, S., Michelakis, E. D., Porter, C. J., Andrade-Navarro, M. A., Thébaud, B., Bonnet, S., Haromy, A., Harry, G., Moudgil, R., McMurtry, M. S., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.609008 · Cited by 590
Self-citationEddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K., & Archer, S. (2002) · Circulation · doi:10.1161/01.cir.0000016641.12984.dc · Cited by 577
Self-citationNagaya, N., Nishikimi, T., Okano, Y., Uematsu, M., Satoh, T., Kyotani, S., Kuribayashi, S., Hamada, S., Kakishita, M., Nakanishi, N., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00452-x · Cited by 574
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J.-M., Scrobohaci, M.-L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 560
Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease
Alp, N. J., & Channon, K. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000110785.96039.f6 · Cited by 531
Nagendran, J., Archer, S. L., Soliman, D., Gurtu, V., Moudgil, R., Haromy, A., St. Aubin, C., Webster, L., Rebeyka, I. M., Ross, D. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655266 · Cited by 530
Self-citationNitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.
Stamler, J. S., Loh, E., Roddy, M. A., Currie, K. E., & Creager, M. A. (1994) · Circulation · doi:10.1161/01.cir.89.5.2035 · Cited by 516
Tuder, R. M., Chacon, M., Alger, L., Wang, J., Taraseviciene‐Stewart, L., Kasahara, Y., Cool, C. D., Bishop, A. E., Geraci, M., Semenza, G. L., et al. (2001) · The Journal of Pathology · doi:10.1002/path.953 · Cited by 500
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Ghofrani, H. A., Wiedemann, R., Rose, F., Olschewski, H., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00008 · Cited by 496
Acute Oxygen-Sensing Mechanisms
Weir, E. K., López-Barneo, J., Buckler, K. J., & Archer, S. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050002 · Cited by 492
Self-citationImatinib for the Treatment of Pulmonary Arterial Hypertension
Ghofrani, H. A., Seeger, W., & Grimminger, F. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051946 · Cited by 492
Barst, R. J., Langleben, D., Badesch, D., Frost, A., Lawrence, E. C., Shapiro, S., Naeije, R., & Galie, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.057 · Cited by 478
Zhao, Y. D., Courtman, D. W., Deng, Y., Kugathasan, L., Zhang, Q., & Stewart, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000157672.70560.7b · Cited by 469
Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 465
McMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000145360.16770.9f · Cited by 453
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Hopkins, W. E., Ochoa, L. L., Richardson, G., & Trulock, E. P. (1996) · PubMed · Cited by 444
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
A USA-based registry for pulmonary arterial hypertension: 1982–2006
Thenappan, T., Shah, S. J., Rich, S., & Gomberg-Maitland, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042107 · Cited by 432
Yu, Y., Fantozzi, I., Remillard, C. V., Landsberg, J. W., Kunichika, N., Platoshyn, O., Tigno, D. D., Thistlethwaite, P. A., Rubin, L. J., & Yuan, J. X.-J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405908101 · Cited by 430
Yuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S. P., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 425
Disruption of methylarginine metabolism impairs vascular homeostasis
Leiper, J., Nandi, M., Torondel, B., Murray-Rust, J., Malaki, M., O'Hara, B., Rossiter, S., Anthony, S., Madhani, M., Selwood, D., et al. (2007) · Nature Medicine · doi:10.1038/nm1543 · Cited by 402
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Xu, W., Koeck, T., Lara, A. R., Neumann, D., DiFilippo, F. P., Koo, M., Janocha, A. J., Masri, F. A., Arroliga, A. C., Jennings, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605080104 · Cited by 395
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
Wilkins, M. R., Paul, G. A., Strange, J. W., Tunariu, N., Gin-Sing, W., Banya, W. A., Westwood, M. A., Stefanidis, A., Ng, L. L., Pennell, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1411oc · Cited by 380
Self-citationMichelakis, E. D., McMurtry, M. S., Wu, X.-C., Dyck, J. R. B., Moudgil, R., Hopkins, T. A., Lopaschuk, G. D., Puttagunta, L., Waite, R., & Archer, S. L. (2002) · Circulation · doi:10.1161/hc0202.101974 · Cited by 369
Self-citationMcMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Hansmann, G., de Jesus Perez, V. A., Alastalo, T.-P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32503 · Cited by 367
Archer, S. L., Gomberg-Maitland, M., Maitland, M. L., Rich, S., Garcia, J. G. N., & Weir, E. K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01324.2007 · Cited by 366
Self-citationOxidative Stress in Severe Pulmonary Hypertension
Bowers, R., Cool, C., Murphy, R. C., Tuder, R. M., Hopken, M. W., Flores, S. C., & Voelkel, N. F. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-147oc · Cited by 366
Hansmann, G., Wagner, R. A., Schellong, S., de Jesus Perez, V. A., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., & Rabinovitch, M. (2007) · Circulation · doi:10.1161/circulationaha.106.663120 · Cited by 366
Bonnet, S., Rochefort, G., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610467104 · Cited by 364
Self-citationLong-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Golovina, V. A., Platoshyn, O., Bailey, C. L., Wang, J., Limsuwan, A., Sweeney, M., Rubin, L. J., & Yuan, J. X.-J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h746 · Cited by 352
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
Petkov, V., Mosgoeller, W., Ziesche, R., Raderer, M., Stiebellehner, L., Vonbank, K., Funk, G.-C., Hamilton, G., Novotny, C., Burian, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17500 · Cited by 352
Oka, M., Homma, N., Taraseviciene-Stewart, L., Morris, K. G., Kraskauskas, D., Burns, N., Voelkel, N. F., & McMurtry, I. F. (2007) · Circulation Research · doi:10.1161/01.res.0000261658.12024.18 · Cited by 331
Teichert-Kuliszewska, K., Kutryk, M. J. B., Kuliszewski, M. A., Karoubi, G., Courtman, D. W., Zucco, L., Granton, J., & Stewart, D. J. (2006) · Circulation Research · doi:10.1161/01.res.0000200180.01710.e6 · Cited by 331
Wang, X.-X., Zhang, F.-R., Shang, Y.-P., Zhu, J.-H., Xie, X.-D., Tao, Q.-M., Zhu, J.-H., & Chen, J.-Z. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.037 · Cited by 322
Piao, L., Fang, Y.-H., Cadete, V. J. J., Wietholt, C., Urboniene, D., Toth, P. T., Marsboom, G., Zhang, H. J., Haber, I., Rehman, J., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0524-6 · Cited by 320
Self-citationNunes, H., Humbert, M., Sitbon, O., Morse, J. H., Deng, Z., Knowles, J. A., Le Gall, C., Parent, F., Garcia, G., Hervé, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-330oc · Cited by 317
Cowan, K. N., Jones, P. L., & Rabinovitch, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6539 · Cited by 302
Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells
Sakao, S., Taraseviciene‐Stewart, L., Lee, J. D., Wood, K., Cool, C. D., & Voelkel, N. F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3261fje · Cited by 301
Attenuated K+ channel gene transcription in primary pulmonary hypertension
Yuan, X.-J., Wang, J., Juhaszova, M., Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 298
Mandegar, M., Fung, Y.-C. B., Huang, W., Remillard, C. V., Rubin, L. J., & Yuan, J. X.-J. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.06.001 · Cited by 293
Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms
Roche, T. E., Baker, J. C., Yan, X., Hiromasa, Y., Gong, X., Peng, T., Dong, J., Turkan, A., & Kasten, S. A. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)70013-x · Cited by 274
Geraci, M. W., Moore, M., Gesell, T., Yeager, M. E., Alger, L., Golpon, H., Gao, B., Loyd, J. E., Tuder, R. M., & Voelkel, N. F. (2001) · Circulation Research · doi:10.1161/01.res.88.6.555 · Cited by 267
West, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126047.82846.20 · Cited by 263
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
Roberts, K. E., McElroy, J. J., Wong, W. P. K., Yen, E., Widlitz, A., Barst, R. J., Knowles, J. A., & Morse, J. H. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00018604 · Cited by 262
Pozeg, Z. I., Michelakis, E. D., McMurtry, M. S., Thébaud, B., Wu, X.-C., Dyck, J. R. B., Hashimoto, K., Wang, S., Moudgil, R., Harry, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000062688.76508.b3 · Cited by 260
Self-citationLong, L., Crosby, A., Yang, X., Southwood, M. R., Upton, P. D., Kim, D.-K., & Morrell, N. W. (2009) · Circulation · doi:10.1161/circulationaha.108.821504 · Cited by 259
Activation of K+channels: an essential pathway in programmed cell death
Remillard, C. V., & Yuan, J. X.-J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2003 · Cited by 251
Steudel, W., Ichinose, F., Huang, P. L., Hurford, W. E., Jones, R. C., Bevan, J. A., Fishman, M. C., & Zapol, W. M. (1997) · Circulation Research · doi:10.1161/01.res.81.1.34 · Cited by 251
Hong, K.-H., Lee, Y. J., Lee, E., Park, S. O., Han, C., Beppu, H., Li, E., Raizada, M. K., Bloch, K. D., & Oh, S. P. (2008) · Circulation · doi:10.1161/circulationaha.107.736801 · Cited by 248
Genetic basis of pulmonary arterial hypertension
Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A., Knowles, J. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.028 · Cited by 247
Davie, N. J., Crossno, J. T., Frid, M. G., Hofmeister, S. E., Reeves, J. T., Hyde, D. M., Carpenter, T. C., Brunetti, J. A., McNiece, I. K., & Stenmark, K. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00108.2003 · Cited by 247
Merklinger, S. L., Jones, P. L., Martinez, E. C., & Rabinovitch, M. (2005) · Circulation · doi:10.1161/circulationaha.105.540542 · Cited by 245
Mechanisms for Increased Glycolysis in the Hypertrophied Rat Heart
Nascimben, L., Ingwall, J. S., Lorell, B. H., Pinz, I., Schultz, V., Tornheim, K., & Tian, R. (2004) · Hypertension · doi:10.1161/01.hyp.0000144292.69599.0c · Cited by 242
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
Schermuly, R. T., Stasch, J.-P., Pullamsetti, S. S., Middendorff, R., Müller, D., Schlüter, K.-D., Dingendorf, A., Hackemack, S., Kolosionek, E., Kaulen, C., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00114407 · Cited by 237
Eddahibi, S., Chaouat, A., Morrell, N., Fadel, E., Fuhrman, C., Bugnet, A.-S., Dartevelle, P., Housset, B., Hamon, M., Weitzenblum, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091409.53101.e8 · Cited by 234
Nagaya, N., Kangawa, K., Kanda, M., Uematsu, M., Horio, T., Fukuyama, N., Hino, J., Harada-Shiba, M., Okumura, H., Tabata, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000079161.56080.22 · Cited by 227
Diller, G.-P., van Eijl, S., Okonko, D. O., Howard, L. S., Ali, O., Thum, T., Wort, S. J., Bédard, E., Gibbs, J. S. R., Bauersachs, J., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769646 · Cited by 224
Self-citationPhosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
Archer, S. L., & Michelakis, E. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0904473 · Cited by 224
Self-citationDumitrascu, R., Weissmann, N., Ghofrani, H. A., Dony, E., Beuerlein, K., Schmidt, H., Stasch, J.-P., Gnoth, M. J., Seeger, W., Grimminger, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.581405 · Cited by 224
Primary Pulmonary Hypertension Between Inflammation and Cancer
Voelkel, N. F., Cool, C., Lee, S. D., Wright, L., Geraci, M. W., & Tuder, R. M. (1998) · Chest · doi:10.1378/chest.114.3_supplement.225s · Cited by 221
Smirnov, S. V., Robertson, T. P., Ward, J. P., & Aaronson, P. I. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.1.h365 · Cited by 218
Fantozzi, I., Zhang, S., Platoshyn, O., Remillard, C. V., Cowling, R. T., & Yuan, J. X.-J. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00445.2002 · Cited by 198
Guignabert, C., Izikki, M., Tu, L. I., Li, Z., Zadigue, P., Barlier-Mur, A.-M., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000222546.45372.a0 · Cited by 196
Evidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-Phenylbutyrate
Zeitlin, P. L., Diener-West, M., Rubenstein, R. C., Boyle, M. P., Lee, C. K. K., & Brass-Ernst, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0639 · Cited by 194
Archer, S. L., Wu, X.-C., Thébaud, B., Nsair, A., Bonnet, S., Tyrrell, B., McMurtry, M. S., Hashimoto, K., Harry, G., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000137173.42723.fb · Cited by 192
Self-citationSimvastatin Attenuates Smooth Muscle Neointimal Proliferation and Pulmonary Hypertension in Rats
Nishimura, T., Faul, J. L., Berry, G. J., Vaszar, L. T., Qiu, D., Pearl, R. G., & Kao, P. N. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200203-268oc · Cited by 191
Yu, Y., Keller, S. H., Remillard, C. V., Safrina, O., Nicholson, A., Zhang, S. L., Jiang, W., Vangala, N., Landsberg, J. W., Wang, J.-Y., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.782458 · Cited by 191
Mittendorf, J., Weigand, S., Alonso‐Alija, C., Bischoff, E., Feurer, A., Gerisch, M., Kern, A., Knorr, A., Lang, D., Muenter, K., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900014 · Cited by 186
Zaidi, S. H. E., You, X.-M., Ciura, S., Husain, M., & Rabinovitch, M. (2002) · Circulation · doi:10.1161/hc0402.102866 · Cited by 186
Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling
Taraseviciene-Stewart, L., Nicolls, M. R., Kraskauskas, D., Scerbavicius, R., Burns, N., Cool, C., Wood, K., Parr, J. E., Boackle, S. A., & Voelkel, N. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1189oc · Cited by 182
Moderate Pulmonary Arterial Hypertension in Male Mice Lacking the Vasoactive Intestinal Peptide Gene
Said, S. I., Hamidi, S. A., Dickman, K. G., Szema, A. M., Lyubsky, S., Lin, R. Z., Jiang, Y.-P., Chen, J. J., Waschek, J. A., & Kort, S. (2007) · Circulation · doi:10.1161/circulationaha.106.681718 · Cited by 177
Pullamsetti, S., Kiss, L., Ghofrani, H. A., Voswinckel, R., Haredza, P., Klepetko, W., Aigner, C., Fink, L., Muyal, J. P., Weissmann, N., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3223fje · Cited by 176
Chronic hypoxia decreases KVchannel expression and function in pulmonary artery myocytes
Platoshyn, O., Yu, Y., Golovina, V. A., McDaniel, S. S., Krick, S., Li, L., Wang, J.-Y., Rubin, L. J., & Yuan, J. X.-J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.4.l801 · Cited by 174
Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension
Asosingh, K., Aldred, M. A., Vasanji, A., Drazba, J., Sharp, J., Farver, C., Comhair, S. A. A., Xu, W., Licina, L., Huang, L., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070705 · Cited by 174
Association of the metabolic syndrome with pulmonary venous hypertension
Robbins, I. M., Newman, J. H., Johnson, R. F., Hemnes, A. R., Fremont, R. D., Piana, R. N., Zhao, D. X., & Byrne, D. W. (2009) · Chest · doi:10.1378/chest.08-2008 · Cited by 171
Factors Influencing the Idiopathic Development of Pulmonary Hypertension in the Fawn Hooded Rat
Sato, K., Webb, S. A., Tucker, A., Rabinovitch, M., OʼBrien, R. F., McMurtry, I. F., & Stelzner, T. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.793 · Cited by 167
AMP-Activated Protein Kinase: A Key Stress Signaling Pathway in the Heart
Young, L. H., Li, J., Baron, S. J., & Russell, R. R. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.04.005 · Cited by 166
Remillard, C. V., Tigno, D. D., Platoshyn, O., Burg, E. D., Brevnova, E. E., Conger, D., Nicholson, A., Rana, B. K., Channick, R. N., Rubin, L. J., et al. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00405.2006 · Cited by 165
Inhaled NO as a therapeutic agent
BLOCH, K., ICHINOSE, F., ROBERTSJR, J., & ZAPOL, W. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.014 · Cited by 159
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
Crossno, J. T., Garat, C. V., Reusch, J. E. B., Morris, K. G., Dempsey, E. C., McMurtry, I. F., Stenmark, K. R., & Klemm, D. J. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00258.2006 · Cited by 158
Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension
Bonnet, S., de la Roque, E. D., Bégueret, H., Marthan, R., Fayon, M. J., Santos, P. D. D., Savineau, J., & Baulieu, É.-É. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633724100 · Cited by 154
Pivotal Role for Endothelial Tetrahydrobiopterin in Pulmonary Hypertension
Khoo, J. P., Zhao, L., Alp, N. J., Bendall, J. K., Nicoli, T., Rockett, K. A., Wilkins, M. R., & Channon, K. M. (2005) · Circulation · doi:10.1161/01.cir.0000162470.26840.89 · Cited by 154
Self-citationAlterations in a redox oxygen sensing mechanism in chronic hypoxia
Reeve, H. L., Michelakis, E. D., Nelson, D. P., Weir, Ε. K., & Archer, S. L. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.6.2249 · Cited by 151
Self-citationBone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension
Reynolds, A. M., Xia, W., Holmes, M., Hodge, S. J., Danilov, S. M., Curiel, D. T., Morrell, N. W., & Reynolds, P. N. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2006 · Cited by 147
Ishigami, M., Swertfeger, D. K., Granholm, N. A., & Hui, D. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20156 · Cited by 144
Zhu, J., Wang, X. X., Zhang, F. R., Shang, Y., Tao, Q., Zhu, J. H., & Chen, J. Z. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00863.x · Cited by 142
JunHui, Z., XingXiang, W., Guo-sheng, F., YunPeng, S., FuRong, Z., & JunZhu, C. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.12.030 · Cited by 130
Morecroft, I., Dempsie, Y., Bäder, M., Walther, D. J., Kotnik, K., Loughlin, L., Nilsen, M., & MacLean, M. R. (2006) · Hypertension · doi:10.1161/01.hyp.0000252210.58849.78 · Cited by 128
Bulau, P., Zakrzewicz, D., Kitowska, K., LEIPER, J. M., Günther, A., Grimminger, F., & Eickelberg, O. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00076.2006 · Cited by 127
Pulmonary Vascular Disease in the Developing World
BUTROUS, G. S., Ghofrani, H. A., & Grimminger, F. (2008) · Circulation · doi:10.1161/circulationaha.107.727289 · Cited by 115
Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension
Archer, S. L., Djaballah, K., Humbert, M. J. C., Weir, Ε. K., Fartoukh, M. S., DALL'AVA-SANTUCCI, J., Mercier, J., Simonneau, G., & Dinh‐Xuan, A. T. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9802113 · Cited by 112
Self-citationProliferation and Signaling in Fibroblasts
Welsh, D., Harnett, M. M., MacLean, M. R., & Peacock, A. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-264oc · Cited by 112
Nagaya, N., Kyotani, S., Uematsu, M., Ueno, K., Oya, H., Nakanishi, N., Shirai, M., Mori, H., Miyatake, K., & Kangawa, K. (2004) · Circulation · doi:10.1161/01.cir.0000109493.05849.14 · Cited by 111
Gomberg‐Maitland, M., Maitland, M. L., Barst, R. J., Sugeng, L., Coslet, S., Perrino, T. J., Bond, L. R., Lacouture, M. E., Archer, S. L., & Ratain, M. J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.217 · Cited by 109
Self-citationCalcium and TRP Channels in Pulmonary Vascular Smooth Muscle Cell Proliferation
Landsberg, J. W., & Yuan, J. X. ‐. (2004) · Physiology · doi:10.1152/nips.01457.2003 · Cited by 109
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure
Hampl, V., Archer, S. L., Nelson, D. P., & Weir, Ε. K. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.4.1748 · Cited by 105
Self-citationYang, J. H., Davies, R. J., Southwood, M. R., Long, L., Yang, X., Sobolewski, A., Upton, P. D., Trembath, R. C., & Morrell, N. W. (2008) · Circulation Research · doi:10.1161/circresaha.108.173567 · Cited by 104
Serotonin Transporter Polymorphisms in Familial and Idiopathic Pulmonary Arterial Hypertension
Willers, E. D., Newman, J. H., Loyd, J. E., Robbins, I. M., Wheeler, L. A., Prince, M., Stanton, K. C., Cogan, J. D., Runo, J. R., Byrne, D. W., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1361oc · Cited by 103
Guignabert, C., Tu, L., Izikki, M., Dewachter, L., Zadigue, P., Humbert, M. J. C., Adnot, S., Fadel, É., & Eddahibi, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-131664 · Cited by 101
Elastase and the Pathobiology of Unexplained Pulmonary Hypertension
Rabinovitch, M. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.213s · Cited by 100
Sobolewski, A., Rudarakanchana, N., Upton, P. D., Yang, J. H., Crilley, T. K., Trembath, R. C., & Morrell, N. W. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn214 · Cited by 97
Dempsie, Y., Morecroft, I., Welsh, D., MacRitchie, N. A., Herold, N., Loughlin, L., Nilsen, M., Peacock, A. J., Harmar, A. J., Bäder, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.767558 · Cited by 96
Zhang, S., Patel, H. H., Murray, F., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00214.2006 · Cited by 92
Wohlfart, P., Xu, H., Endlich, A., Habermeier, A., Closs, E. I., Hübschle, T., Mang, C. F., Strobel, H., Suzuki, T. C., Kleinert, H., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128009 · Cited by 92
Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer
Zhao, Y. D., Courtman, D. W., Ng, D. S., Robb, M. J., Deng, Y., Trogadis, J. E., Han, R. N. N., & Stewart, D. J. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0115oc · Cited by 89
Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy
Sharma, S., Taegtmeyer, H., Adrogue, J. V., Razeghi, P., Sen, S., Ngumbela, K. C., & Essop, M. F. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00916.2003 · Cited by 81
Role of endothelium in the maintenance of low pulmonary vascular tone in normal children.
Celermajer, D. S., DOLLERY, C. M., Burch, M., & Deanfield, J. E. (1994) · Circulation · doi:10.1161/01.cir.89.5.2041 · Cited by 79
Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?
Eddahibi, S., Raffestin, B., Hamon, M., & Adnot, S. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.122181 · Cited by 76
Wakino, S., Kintscher, U., Liu, Z., Kim, S., Yin, F., Ohba, M., Kuroki, T., Schönthal, A. H., Hsueh, W. A., & Law, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108719200 · Cited by 72
Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension
Kawut, S. M., Horn, E. M., Berekashvili, K. K., Lederer, D. J., Widlitz, A. C., Rosenzweig, E. B., & Barst, R. J. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2006.01.001 · Cited by 71
Baliga, R. S., Zhao, L., Madhani, M., Torondel, B., Visintin, C., Selwood, D. L., Wilkins, M. R., MacAllister, R. J., & Hobbs, A. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-121oc · Cited by 70
Self-citationVermeersch, P., Buys, E. S., Pokreisz, P., Marsboom, G., Ichinose, F., Sips, P. Y., Pellens, M., Gillijns, H., Swinnen, M., Graveline, A. R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.677245 · Cited by 68
Deruelle, P., Grover, T. R., & Abman, S. H. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00119.2005 · Cited by 67
AMPK and metabolic adaptation by the heart to pressure overload
Allard, M. F., Parsons, H. L., Saeedi, R., Wambolt, R. B., & Brownsey, R. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00424.2006 · Cited by 65
Nitric Oxide Synthase in Pulmonary Hypertension: Lessons from Knockout Mice
Fagan, K. A., McMurtry, I. F., & Rodman, D. M. (2000) · Physiological Research · doi:10.33549/physiolres.930000.49.539 · Cited by 57
Faber, L., Seggewiß, H., Faßbender, D., Strick, S., Bogunovic, N., & Gleichmann, U. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)81515-5 · Cited by 55
Nagaya, N., Okumura, H., Uematsu, M., Shimizu, W., Ono, F., Shirai, M., Mori, H., Miyatake, K., & Kangawa, K. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00548.2002 · Cited by 51
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.
Hampl, V., Tristani‐Firouzi, M., Hutsell, T. C., et al. (1996) · PubMed · Cited by 50
c-Jun Decreases Voltage-Gated K + Channel Activity in Pulmonary Artery Smooth Muscle Cells
Yu, Y., Platoshyn, O., Zhang, J., Krick, S., Zhao, Y., Rubin, L. J., Rothman, A., & Yuan, J. X. ‐. (2001) · Circulation · doi:10.1161/hc3801.095662 · Cited by 50
AMP‐activated protein kinase and the regulation of Ca2+ signalling in O2‐sensing cells
Evans, A. M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108381 · Cited by 47
Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats
Suzuki, C., Takahashi, M., Morimoto, H., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.109 · Cited by 44
Mair, K. M., MacLean, M. R., Morecroft, I., Dempsie, Y., & Palmer, T. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.310 · Cited by 42
Bayrak, F., Kömürcü-Bayrak, E., Mutlu, B., Kahvecı, G., Başaran, Y., & Erginel‐Ünaltuna, N. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.03.006 · Cited by 34
Dexfenfluramine protects against pulmonary hypertension in rats
Mitani, Y., Mutlu, A., Russell, J. C., Brindley, D. N., DeAlmeida, J., & Rabinovitch, M. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00500.2002 · Cited by 25
Lam, C., van Heerden, P. V., Blott, J. A., Roberts, B., & Ilett, K. F. (2004) · Journal of Critical Care · doi:10.1016/j.jcrc.2004.02.009 · Cited by 23
Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary Hypertension
Pérez-Peñate, G. M., Juliá-Serdà, G., Ojeda-Betancort, N., Quintana, A. G., Pulido-Duque, J. M., Rodríguez, A., Cabrera-Navarro, P., & Gómez‐Sánchez, M. Á. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.08.007 · Cited by 19
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension
Hampl, V., Tristani-Firouzi, M., Hutsell, T. C., & Archer, S. L. (1996) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00172-7 · Cited by 18
Self-citationNandi, M., LEIPER, J. M., Arrigoni, F., Hislop, A. A., Vallance, P. J., & Haworth, S. G. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000219301.19958.a0 · Cited by 16
Spotlight on Sapropterin in Primary Hyperphenylalaninemia†
Sanford, M., & Keating, G. M. (2009) · BioDrugs · doi:10.2165/00063030-200923030-00007 · Cited by 5
Cited by
Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases
Archer, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215233 · Cited by 1,102
Self-citationNew developments in mast cell biology
Kalesnikoff, J., & Galli, S. J. (2008) · Nature Immunology · doi:10.1038/ni.f.216 · Cited by 748
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
Tuder, R. M., Archer, S. L., Dorfmüller, P., Erzurum, S. C., Guignabert, C., Michelakis, E., Rabinovitch, M., Schermuly, R., Stenmark, K. R., & Morrell, N. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.025 · Cited by 585
Self-citationBrozovich, F. V., Nicholson, C. J., Degen, C. V., Gao, Y. Z., Aggarwal, M., & Morgan, K. G. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010652 · Cited by 542
Metadata
- Authors
- Archer, S. L., Weir, E. K., & Wilkins, M. R.
- Venue
- Circulation
- Published
- 2010-05-11
- Volume
- 121
- Issue
- 18
- Pages
- 2045-2066
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2065501812
- Cited by
- 485
- References
- 166
- FWCI
- 36.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.